Multicenter Validation of a Bedside Antisaccade Task As a Measure of Executive Function

Overview

Journal Neurology

Specialty Neurology

Date 2012 May 11

PMID 22573640

Citations 25

Authors

J Hellmuth

J Mirsky

H W Heuer

A Matlin

A Jafari

S Garbutt

M Widmeyer

A Berhel

L Sinha

B L Miller

J H Kramer

A L Boxer

Affiliations

Soon will be listed here.

Abstract

Objective: To create and validate a simple, standardized version of the antisaccade (AS) task that requires no specialized equipment for use as a measure of executive function in multicenter clinical studies.

Methods: The bedside AS (BAS) task consisted of 40 pseudorandomized AS trials presented on a laptop computer. BAS performance was compared with AS performance measured using an infrared eye tracker in normal elders (NE) and individuals with mild cognitive impairment (MCI) or dementia (n = 33). The neuropsychological domain specificity of the BAS was then determined in a cohort of NE, MCI, and dementia (n = 103) at UCSF, and the BAS was validated as a measure of executive function in a 6-center cohort (n = 397) of normal adults and patients with a variety of brain diseases.

Results: Performance on the BAS and laboratory AS task was strongly correlated and BAS performance was most strongly associated with neuropsychological measures of executive function. Even after controlling for disease severity and processing speed, BAS performance was associated with multiple assessments of executive function, most strongly the informant-based Frontal Systems Behavior Scale.

Conclusions: The BAS is a simple, valid measure of executive function in aging and neurologic disease.

Citing Articles

Cognitive control in individuals with heroin use disorder after prolonged methadone maintenance treatment.

Zhao W, Duan F, Li X, Li J, Xia L, Ren Z BMC Psychiatry. 2025; 25(1):78.

PMID: 39875922 PMC: 11773829. DOI: 10.1186/s12888-025-06523-x.

The application of saccades to assess cognitive impairment among older adults: a systematic review and meta-analysis.

Zhang S, Huang X, An R, Xiao W, Wan Q Aging Clin Exp Res. 2023; 35(11):2307-2321.

PMID: 37676429 DOI: 10.1007/s40520-023-02546-0.

Investigating the Impact of Guided Imagery on Stress, Brain Functions, and Attention: A Randomized Trial.

Zemla K, Sedek G, Wrobel K, Postepski F, Wojcik G Sensors (Basel). 2023; 23(13).

PMID: 37448060 PMC: 10346678. DOI: 10.3390/s23136210.

Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases.

Riek H, Brien D, Coe B, Huang J, Perkins J, Yep R Brain Commun. 2023; 5(2):fcad049.

PMID: 36970045 PMC: 10036290. DOI: 10.1093/braincomms/fcad049.

Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression.

McLennan Y, Mosconi M, McKenzie F, Famula J, Krawchuk B, Kim K Mov Disord Clin Pract. 2022; 9(4):473-478.

PMID: 35586536 PMC: 9092736. DOI: 10.1002/mdc3.13449.

References

Meyniel C, Rivaud-Pechoux S, Damier P, Gaymard B . Saccade impairments in patients with fronto-temporal dementia. J Neurol Neurosurg Psychiatry. 2005; 76(11):1581-4. PMC: 1739401. DOI: 10.1136/jnnp.2004.060392. View

Munoz D, Everling S . Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci. 2004; 5(3):218-28. DOI: 10.1038/nrn1345. View

Boxer A, Garbutt S, Rankin K, Hellmuth J, Neuhaus J, Miller B . Medial versus lateral frontal lobe contributions to voluntary saccade control as revealed by the study of patients with frontal lobe degeneration. J Neurosci. 2006; 26(23):6354-63. PMC: 2551317. DOI: 10.1523/JNEUROSCI.0549-06.2006. View

Levy D, Mendell N, Holzman P . The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations. World Psychiatry. 2006; 3(1):32-40. PMC: 1414662. View

McDonald S, Flanagan S, Rollins J, Kinch J . TASIT: A new clinical tool for assessing social perception after traumatic brain injury. J Head Trauma Rehabil. 2003; 18(3):219-38. DOI: 10.1097/00001199-200305000-00001. View

Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51(6):1546-54. DOI: 10.1212/wnl.51.6.1546. View

Blekher T, Johnson S, Marshall J, White K, Hui S, Weaver M . Saccades in presymptomatic and early stages of Huntington disease. Neurology. 2006; 67(3):394-9. DOI: 10.1212/01.wnl.0000227890.87398.c1. View

Currie J, Ramsden B, McArthur C, Maruff P . Validation of a clinical antisaccadic eye movement test in the assessment of dementia. Arch Neurol. 1991; 48(6):644-8. DOI: 10.1001/archneur.1991.00530180102024. View

Tabrizi S, Langbehn D, Leavitt B, Roos R, Durr A, Craufurd D . Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009; 8(9):791-801. PMC: 3725974. DOI: 10.1016/S1474-4422(09)70170-X. View

10.

Hodgson T, Chamberlain M, Parris B, James M, Gutowski N, Husain M . The role of the ventrolateral frontal cortex in inhibitory oculomotor control. Brain. 2007; 130(Pt 6):1525-37. DOI: 10.1093/brain/awm064. View

11.

Ettinger U, Antonova E, Crawford T, Mitterschiffthaler M, Goswani S, Sharma T . Structural neural correlates of prosaccade and antisaccade eye movements in healthy humans. Neuroimage. 2005; 24(2):487-94. DOI: 10.1016/j.neuroimage.2004.08.019. View

12.

Albanese A . Diagnostic criteria for Parkinson's disease. Neurol Sci. 2003; 24 Suppl 1:S23-6. DOI: 10.1007/s100720300032. View

13.

Hutton S, Huddy V, Barnes T, Robbins T, Crawford T, Kennard C . The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia. Biol Psychiatry. 2004; 56(8):553-9. DOI: 10.1016/j.biopsych.2004.07.002. View

14.

Zanelli J, MacCabe J, Toulopoulou T, Walshe M, McDonald C, Murray R . Neuropsychological correlates of eye movement abnormalities in schizophrenic patients and their unaffected relatives. Psychiatry Res. 2009; 168(3):193-7. DOI: 10.1016/j.psychres.2008.05.008. View

15.

Golding C, Danchaivijitr C, Hodgson T, Tabrizi S, Kennard C . Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. 2006; 67(3):485-7. DOI: 10.1212/01.wnl.0000218215.43328.88. View

16.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin R . Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996; 47(1):1-9. DOI: 10.1212/wnl.47.1.1. View

17.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

18.

Radant A, Dobie D, Calkins M, Olincy A, Braff D, Cadenhead K . Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2006; 89(1-3):320-9. DOI: 10.1016/j.schres.2006.08.010. View

19.

Malloy P, Grace J . A review of rating scales for measuring behavior change due to frontal systems damage. Cogn Behav Neurol. 2005; 18(1):18-27. DOI: 10.1097/01.wnn.0000152232.47901.88. View

20.

Broerse A, Holthausen E, van den Bosch R, den Boer J . Does frontal normality exist in schizophrenia? A saccadic eye movement study. Psychiatry Res. 2001; 103(2-3):167-78. DOI: 10.1016/s0165-1781(01)00275-x. View